Countries North America
US leads on drug device innovation but trails Europe on sustainability
Ahead of the first Pharmapack Europe to be held in nearly 18-months, Informa has released the results of its global drug delivery and packaging s...
September 16, 2021 | News
Life Sciences' Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users
Frost & Sullivan's recent analysis finds that digital therapeutics (DTx) in the United States are considered legitimate alternatives to tradi...
August 10, 2021 | News
ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio
When paired with the ORTHO™ Workstation, the ORTHO OPTIX Reader provides a complete semi-automated testing platform for transfusion labs with low- to...
July 26, 2021 | News
OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies
OnCusp successfully closed its seed round financing of $25 million on April 1, 2021, led by Sequoia Capital and Biotrack Capital, followed b...
July 01, 2021 | News
BIO to Hold First-Ever Clinical Trial Diversity Summit
The Biotechnology Innovation Organization (BIO) will hold its first-ever BIO Clinical Trial Diversity Summit June 24-25, 2021 to focus on th...
June 22, 2021 | News
MSD Announces Supply Agreement with U.S. Govt. for Molnupiravir
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it has entered into a procurement agreement with&...
June 21, 2021 | News
How Does “No Mask Required” Affect Air Quality and Risk Mitigation Strategies
Can owners and managers of local businesses and workplaces breathe a sigh of relief that they don’t need to worry about Severe Acute Respiratory Synd...
June 16, 2021 | Opinion | By Behind The Bench Staff | ThermoFisher
BIO Elects Paul Hastings as New Board Chair
The Biotechnology Innovation Organization (BIO) today announced the election of Paul J. Hastings, President and Chief Executive Officer of Nkarta Ther...
June 14, 2021 | News
Vicore announces FDA acceptance of C21 in COVID-19
ATTRACT-3 trial is a randomized, double-blind, placebo-controlled, multinational, phase 3 trial that will include 600 adult patients hospitalized with COVI...
June 14, 2021 | News
FDA Takes Steps to Increase Availability of COVID-19 Vaccine
The agency is announcing today that it is authorizing for use, under the emergency use authorization (EUA) for the Janssen COVID-19 vaccine, two batches of...
June 12, 2021 | News
Avantor® Completes Acquisition of Ritter GmbH and its Affiliates
By combining Ritter's liquid dispensing platform for clinical diagnostic testing and life sciences research with Avantor's offerings for critical lab autom...
June 12, 2021 | News
SAS delivers free analytics training for COVID researchers
Analytics leader SAS is increasing its support of COVID researchers through new, free analytics training options. A year ago, SAS provided free use of ...
June 11, 2021 | News
Explora BioLabs Acquires Cambridge Vivarium Service Provider Novalex
Explora BioLabs, a national provider of preclinical vivarium space, vivarium management services, and contract research services, today announced it ...
June 11, 2021 | News
iResearch Atlanta welcomes new investigators and expands its operations
iResearch Atlanta welcomes new investigators and expands its operations to serve more patients in phase I-IV clinical trials, the ability to cont...
June 10, 2021 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
